Search - tctmd.com

Displaying 741 - 760 of 993

Sort: Relevancy | Date

Presentation TVT 2017

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: David J. Cohen, Jeffrey J. Popma, Nicolas M. Van Mieghem

June 16, 2017

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

News Daily News

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Michael O'Riordan

March 15, 2017

News Conference News CRT 2017

Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases

Michael O'Riordan

February 21, 2017

News Daily News

Transferred STEMI Patients Have Worse Mortality at 1 Year, Registry Shows

L.A. McKeown

February 15, 2017

News Daily News

Most Patients With Heart Failure Are Missing the Boat on Flu, Pneumococcal Vaccines

Todd Neale

February 03, 2017

News Daily News

AHA/ACC Report Recommends 10 Measures to Prevent Sudden Cardiac Death

Leah Lawrence

December 23, 2016

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Shelley Wood

November 16, 2016

News Conference News AHA 2016

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

Michael O'Riordan

November 16, 2016

Presentation AHA 2016

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

Presenter: David M Kaye

November 15, 2016

News Conference News AHA 2016

The ART of CABG: Bilateral Technique Associated With Similar Outcomes as Single Graft at 5 Years

Yael L. Maxwell

November 14, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Todd Neale

November 01, 2016

Presentation TCT 2016

Novel Device Based Therapy for Heart Failure Preserved Ejection Fraction

Presenter: Daniel Burkhoff, Ileana L. Pina, Samuel J. Asirvatham

October 30, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Conference News PCR London Valves 2016

MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation

Shelley Wood

September 19, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

Advertisement

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases

Transferred STEMI Patients Have Worse Mortality at 1 Year, Registry Shows

Most Patients With Heart Failure Are Missing the Boat on Flu, Pneumococcal Vaccines

AHA/ACC Report Recommends 10 Measures to Prevent Sudden Cardiac Death

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

The ART of CABG: Bilateral Technique Associated With Similar Outcomes as Single Graft at 5 Years

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Novel Device Based Therapy for Heart Failure Preserved Ejection Fraction

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content